Daehan New Pharm Co. Ltd (054670) — Cash Flow-to-Debt Ratio
Daehan New Pharm Co. Ltd (054670) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of ₩4.43 Billion could theoretically repay 0% of its total liabilities (₩122.10 Billion) in one year. Explore 054670 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Daehan New Pharm Co. Ltd Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Daehan New Pharm Co. Ltd across 11 annual periods. Also explore 054670 asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Daehan New Pharm Co. Ltd (2014–2024)
Year-by-year debt coverage analysis for Daehan New Pharm Co. Ltd. For market capitalisation and broader financial context, see Daehan New Pharm Co. Ltd (054670) total market value.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.20x | ₩18.95 Billion | ₩95.85 Billion | ▲ +6.3% |
| 2023 | 0.19x | ₩12.57 Billion | ₩67.57 Billion | ▼ -13.4% |
| 2022 | 0.21x | ₩14.25 Billion | ₩66.40 Billion | ▼ -2.7% |
| 2021 | 0.22x | ₩16.58 Billion | ₩75.18 Billion | ▲ +23.7% |
| 2020 | 0.18x | ₩13.55 Billion | ₩75.95 Billion | ▼ -47.9% |
| 2019 | 0.34x | ₩22.89 Billion | ₩66.84 Billion | ▲ +9.8% |
| 2018 | 0.31x | ₩20.47 Billion | ₩65.66 Billion | ▲ +1001.6% |
| 2017 | -0.03x | ₩-2.42 Billion | ₩70.09 Billion | ▼ -123.5% |
| 2016 | 0.15x | ₩8.75 Billion | ₩59.52 Billion | ▲ +4.4% |
| 2015 | 0.14x | ₩7.80 Billion | ₩55.43 Billion | ▼ -20.5% |
| 2014 | 0.18x | ₩10.02 Billion | ₩56.58 Billion | — |